Menu

Editing Human Blood Vessel Cells with CRISPR

Researchers use the genome-editing tool to manipulate cultured human endothelial cells.

May 5, 2015
Jenny Rood

WIKIMEDIA, KLINTWORTH GK

Human endothelial cells that make up the lining of blood vessels can be genetically altered using the CRISPR/Cas9 system, according to a study published today (May 4) in Circulation Research.

In addition to animal models, human endothelial cells grown in tissue culture provide a valuable model to understand the biology of blood vessels. Additionally, research using the cells may one day contribute to the development of methods to heal tissues by engineering them in the lab. However, because the cells are already highly specialized, they have been difficult to manipulate genetically to probe the functions of particular genes in biological processes.

In the first reported use of the CRISPR/Cas9 technique in human endothelial cells, researchers from the Yale University School of Medicine infected cultured endothelial cells with a virus containing the instructions for a Cas9 enzyme. The enzyme was designed to eliminate the gene CIITA, which encodes a transcription factor that controls the expression of class II major histocompatibility complex molecules. After treating the cells with virus, the researchers were able to remove both copies of the gene from 40 percent of the cells. As a result, the cells lacking CIITA no longer produced the immune response that activates T cells in response to foreign invaders, but were otherwise able to function normally. For example, the edited cells could still assemble into blood vessels in vitro and incorporate into mouse blood vessels in vivo.

The specialization of CRISPR/Cas9 for endothelial cells offers a “provides a powerful platform for vascular research and for regenerative medicine,” the authors wrote in their paper. “The specific changes we describe might be important for using these cells in therapeutic applications such as organ repair or tissue engineering.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.